Literature DB >> 31211445

DNA hypomethylation promotes invasion and metastasis of gastric cancer cells by regulating the binding of SP1 to the CDCA3 promoter.

Jiawei Yu1, Ruheng Hua1, Yan Zhang2, Ran Tao1, Quhui Wang1, Qingfeng Ni1.   

Abstract

BACKGROUND: Cell division cycle associated protein-3 (CDCA3) has been reported frequently upregulated in various cancers. It has been progressively realized that changed DNA methylations occur in diverse carcinomas. However, the concrete involvement of CDCA3 and DNA methylation in gastric cancer (GC) still needs to be further elucidated.
METHODS: In this study, quantitative reverse-transcription polymerase chain reaction (PCR) was utilized to determine the relative expressions of CDCA3 in GC and normal tissue samples. The methylation condition of CDCA3 was determined by bisulfite-sequencing PCR (BSP) and methylation-specific PCR (MSP). A chromatin immunoprecipitation (ChIP) assay and luciferase activity assay was used for the interaction between transcription factors and promoters and binding site determination, respectively. The effects of knockdown or overexpression of specificity protein 1 (SP1) or CDCA3 on GC cells in vitro were further assessed via wound healing assay, colony formation assay, and matrigel invasion assay.
RESULTS: In comparison to paired normal tissues, CDCA3 expressions were significantly increased in the GC tissues. The CDCA3 expression was regulated by DNA methylation, with the CpG island hypomethylation responsible for CDCA3 upregulation of GC. ChIP assays verified that the activity of SP1 binding to the CDCA3 promoter was dramatically increased. When the CDCA3 expression was downregulated in MKN45 cells by knockdown SP1, the proliferation ability, healing ability, and invasive ability were significantly suppressed.
CONCLUSION: The process by which SP1 bound to the nearest promoter region was expedited in GC cells, by which DNA was hypomethylated and CDCA3 expression was promoted. The effect on cell proliferation and invasion by CDCA3 was under the regulation of SP1 and also affected by hypomethylation of DNA.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  DNA methylation; cell division cycle associated protein-3; gastric cancer; proliferation; specificity protein 1

Mesh:

Substances:

Year:  2019        PMID: 31211445     DOI: 10.1002/jcb.28993

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  15 in total

1.  The dynamic alteration of transcriptional regulation by crucial TFs during tumorigenesis of gastric cancer.

Authors:  Beiqin Yu; Wentao Dai; Li Pang; Qingqing Sang; Fangyuan Li; Junxian Yu; Haoran Feng; Jianfang Li; Junyi Hou; Chao Yan; Liping Su; Zhenggang Zhu; Yuan-Yuan Li; Bingya Liu
Journal:  Mol Med       Date:  2022-04-14       Impact factor: 6.354

2.  Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.

Authors:  Zeng-Hong Wu; Ming Fang; Yan Zhou
Journal:  PLoS One       Date:  2020-07-27       Impact factor: 3.240

3.  Neuropilin1 Expression Acts as a Prognostic Marker in Stomach Adenocarcinoma by Predicting the Infiltration of Treg Cells and M2 Macrophages.

Authors:  Ji Young Kang; Minchan Gil; Kyung Eun Kim
Journal:  J Clin Med       Date:  2020-05-12       Impact factor: 4.241

4.  Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.

Authors:  Yuenan Liu; Gong Cheng; Ziwei Huang; Lin Bao; Jingchong Liu; Cheng Wang; Zhiyong Xiong; Lijie Zhou; Tianbo Xu; Di Liu; Hongmei Yang; Ke Chen; Xiaoping Zhang
Journal:  Cell Death Dis       Date:  2020-07-08       Impact factor: 8.469

5.  CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis.

Authors:  Dongwei Dou; Xiaoyang Ren; Mingli Han; Xiaodong Xu; Xin Ge; Yuanting Gu; Xinxing Wang; Song Zhao
Journal:  Cancer Cell Int       Date:  2020-09-14       Impact factor: 5.722

6.  Gastrointestinal adenocarcinoma analysis identifies promoter methylation-based cancer subtypes and signatures.

Authors:  Renshen Xiang; Tao Fu
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379

7.  The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma.

Authors:  Dexin Shen; Yayun Fang; Fenfang Zhou; Zhao Deng; Kaiyu Qian; Gang Wang; Yu Xiao; Lingao Ju; Xinghuan Wang
Journal:  Cancer Cell Int       Date:  2021-05-12       Impact factor: 5.722

8.  Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy.

Authors:  Katrina Kildey; Neha S Gandhi; Katherine B Sahin; Esha T Shah; Eric Boittier; Pascal H G Duijf; Christopher Molloy; Joshua T Burgess; Sam Beard; Emma Bolderson; Amila Suraweera; Derek J Richard; Kenneth J O'Byrne; Mark N Adams
Journal:  Commun Biol       Date:  2021-05-28

9.  Signature identification of relapse-related overall survival of early lung adenocarcinoma after radical surgery.

Authors:  Peng Han; Jiaqi Yue; Kangle Kong; Shan Hu; Peng Cao; Yu Deng; Fan Li; Bo Zhao
Journal:  PeerJ       Date:  2021-08-05       Impact factor: 2.984

10.  Effect of Shengmai Yin on the DNA methylation status of nasopharyngeal carcinoma cell and its radioresistant strains.

Authors:  Shiya Liu; Zhiyuan Wang; Daoqi Zhu; Jiabin Yang; Dandan Lou; Ruijiao Gao; Zetai Wang; Aiwu Li; Ying Lv; Qin Fan
Journal:  J Pharm Anal       Date:  2020-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.